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Regulation of cytoskeletal dynamics is essential for cell shape change and morphogenesis. Drosophila melanogaster
embryos offer a well-defined system for observing alterations in the cytoskeleton during the process of cellularization, a
specialized form of cytokinesis. During cellularization, the actomyosin cytoskeleton forms a hexagonal array and drives
invagination of the plasma membrane between the nuclei located at the cortex of the syncytial blastoderm. Rho, Rac, and
Cdc42 proteins are members of the Rho subfamily of Ras-related G proteins that are involved in the formation and
maintenance of the actin cytoskeleton throughout phylogeny and in D. melanogaster. To investigate how Rho subfamily
activity affects the cytoskeleton during cellularization stages, embryos were microinjected with C3 exoenzyme from
Clostridium botulinum or with wild-type, constitutively active, or dominant negative versions of Rho, Rac, and Cdc42
proteins. C3 exoenzyme ADP-ribosylates and inactivates Rho with high specificity, whereas constitutively active dominant
mutations remain in the activated GTP-bound state to activate downstream effectors. Dominant negative mutations likely
inhibit endogenous small G protein activity by sequestering exchange factors. Of the 10 agents microinjected, C3
exoenzyme, constitutively active Cdc42, and dominant negative Rho have a specific and indistinguishable effect: the
actomyosin cytoskeleton is disrupted, cellularization halts, and embryogenesis arrests. Time-lapse video records of DIC
imaged embryos show that nuclei in injected regions move away from the cortex of the embryo, thereby phenocopying
injections of cytochalasin or antimyosin. Rhodamine phalloidin staining reveals that the actin-based hexagonal array
normally seen during cellularization is disrupted in a dose-dependent fashion. Additionally, DNA stain reveals that nuclei
in the microinjected embryos aggregate in regions that correspond to actin disruption. These embryos halt in cellularization
and do not proceed to gastrulation. We conclude that Rho activity and Cdc42 regulation are required for cytoskeletal
function in actomyosin-driven furrow canal formation and nuclear positioning. © 1998 Academic Press
INTRODUCTION
Regulation of cytoskeletal function during cell shape
change, cell sheet movement, and cytokinesis is essential
for cellular homeostasis and development and maintenance
of differentiated states. Cellularization in Drosophila mela-
nogaster is a specialized form of cytokinesis that results in
the synchronous formation of approximately 6000 cells and
is particularly amenable to pharmacological analysis (re-
viewed in Miller and Kiehart, 1995). Immunofluorescence
studies indicate that actin and myosin are localized at the
leading edge of the invaginating furrows in a position to
drive cellularization (Young et al., 1991; Edwards et al.,
1996; Thomas and Kiehart, 1994). Pharmacological inhibi-
tors of the actomyosin network (such as cytochalasin,
phalloidin, and antimyosin; Kiehart et al., 1990; Foe et al.,
1993) and mutations in cytoskeletal components (Karess et
al., 1991; Adams et al., 1993) disrupt normal cytoskeletal
processes, but regulation of the actomyosin network during
cellularization and in other actin-based processes is not
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understood. In this study, we evaluate the role of a subfam-
ily of small p21 GTPase proteins in the regulation of
cytoskeletal dynamics during Drosophila cellularization.
Small p21 GTPases act as molecular switches by inter-
converting between an active, GTP-bound state and an
inactive, GDP-bound state through a GTPase cycle (family
members reviewed in Van Aelst and D’Souza-Schorey,
1997; Hall, 1998). GTP hydrolysis is regulated by GAPs
(GTPase activating proteins), while guanine nucleotide ex-
change is stimulated by both GDSs (guanine nucleotide
dissociation stimulators) and GEFs (guanine nucleotide
exchange factors) and is inhibited by GDIs (guanine nucle-
otide dissociation inhibitors). As with other p21s, the
members of the Rho subfamily (Rho, Rac, and Cdc42)
receive signals from membrane receptors and initiate intra-
cellular responses via cytoplasmic and nuclear signal trans-
duction pathways (Coso et al., 1995; Minden et al., 1995;
Olson et al., 1995; Bagrodia et al., 1995). Morphologically,
Rho, Rac, and Cdc42, respectively, have been implicated in
actin cytoskeletal rearrangements such as focal adhesion
and stress fiber formation (Ridley and Hall, 1992), mem-
brane ruffling (Ridley et al., 1992), and filopodial formation
(Kozma et al., 1995; Nobes and Hall, 1995). Members of the
Rho subfamily are also required for the G1-phase progres-
sion of fibroblasts (Olson et al., 1995) and cytokinesis
(Mabuchi et al., 1993; Larochelle et al., 1996; Drechsel et
al., 1997). In many species, multiple isoforms of the Rho
subfamily exist. The Drosophila Rho subfamily currently
consists of RhoA (Rho1), RhoL, Drac1 (DRacA), Drac2
(DRacB), Drac3, and Dcdc42 (Sasamura et al., 1997). To
date, loss-of-function mutations are only available for RhoA
and Cdc42 (Strutt et al., 1997; Fehon et al., 1997).
A genetic approach to study the function of Rho subfam-
ily members is not available in all systems. For example,
although Drosophila offers a well-characterized and valu-
able genetic model system, the early stages of Drosophila
embryogenesis, including cellularization, are not readily
amenable to genetic manipulation. During cellularization,
maternally loaded gene products are supplied in sufficient
amounts to sustain the zygote until late embryonic or early
larval stages (Schejter and Wieschaus, 1993; Miller and
Kiehart, 1995; Wheatly et al., 1995; Edwards and Kiehart,
1996; Perrimon et al., 1996). In systems where a genetic
approach is not possible, evaluation of the roles of these
p21s in various cellular and developmental processes has
been accomplished through the chemical modification of
Rho and the production of dominant mutations in the Rho
subfamily by site-directed mutagenesis. C3 exoenzyme
from Clostridium botulinum ADP-ribosylates and inacti-
vates Rho-GTP with high specificity (Narumiya et al.,
1988; Aktories et al., 1989; Sekine et al., 1989; Braun et al.,
1989; Menard et al., 1992; Ridley and Hall, 1992; Mabuchi
et al., 1993). Thus, cells microinjected with appropriate
doses of C3 exoenzyme are most likely to behave in a
manner comparable to cells that are genetically null for
Rho. Constitutively active p21s bind GTP, do not respond
to GTPase activating proteins, and show a reduced intrinsic
GTPase activity and thereby remain in an active state (Tong
et al., 1989). Likewise, dominant negative forms of p21s
result in a protein with a preferential binding affinity for
GDP (Feig and Cooper, 1988) and are believed to function by
remaining in a GDP-bound, inactive state that sequesters
guanine nucleotide exchange factors. This prevents the
interaction of these exchange factors with the endogenous,
wild-type counterparts of the p21 proteins (Farnsworth and
Feig, 1991; Ridley and Hall, 1992). Previous studies in
which dominant mutant forms of mammalian small GTP-
binding proteins have been expressed or injected in Dro-
sophila indicate that these molecules can disrupt the sig-
naling carried out by their Drosophila counterparts and
suggest conservation of function across divergent species
(Lu et al., 1996; Strutt et al., 1997; Harden et al., in
preparation). This strategy has shown that each Rho sub-
family member has specific and distinct roles in modulat-
ing the actomyosin cytoskeleton in Drosophila develop-
mental processes (Luo et al., 1994; Eaton et al., 1995, 1996;
Harden et al., 1995; Hariharan et al., 1995; Murphy and
Montell, 1996; Riesgo-Escovar et al., 1996; Strutt et al.,
1997; Kaufmann et al., 1998).
Here we utilize a pharmacological approach to investi-
gate the function of the Rho subfamily during Drosophila
cellularization. C3 exoenzyme and wild-type, constitu-
tively active and dominant negative forms of the Rho, Rac,
and Cdc42 small GTPase proteins were microinjected into
the posterior pole of cellularizing embryos. This pharmaco-
logical approach allows for a spatially and temporally spe-
cific analysis of Rho subfamily function not readily avail-
able through genetic strategies. We show that the process of
cellularization and the structure of the underlying cytoskel-
eton are specifically disrupted by the Rho inhibitor C3
exoenzyme, dominant negative Rho (N19Rho), and consti-
tutively active Cdc42 (V12Cdc42) with phenotypes that are
indistinguishable. The disruption caused by N19Rho and
V12Cdc42 is ameliorated by pre-microinjection of wild-
type or constitutively active versions of some of these p21s.
We conclude that cellularization requires Rho function and
regulated Cdc42 activity.
MATERIALS AND METHODS
Materials
Reagent-grade chemicals were purchased from Sigma (St. Louis,
MO), Baker (Phillipsburg, NJ), or Fisher (Fairlawn, NJ) unless
otherwise specified.
Embryos
In all experiments, klarsicht mutant D. melanogaster embryos that
are optically clear but otherwise wild-type were used (Wieschaus and
Nu¨sslein-Volhard, 1986). Embryos at appropriate stages were col-
lected and chemically dechorionated with 50% bleach for 2 min and
washed thoroughly with deionized water. After aging to the appropri-
ate stage, the embryos were lined up on a square of agar and
transferred en masse to a #1.5 glass coverslip coated with embryo glue
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(Kiehart et al., 1994). The coverslip was mounted on a stainless steel
micromanipulation slide, desiccated for approximately 5 min, and
overlaid with halocarbon oil (HC 700, Sigma Chemical) as described
elsewhere (Kiehart et al., 1994). The mounted embryos were moni-
tored until they reached the appropriate stage.
C3 Exoenzyme and Rho Subfamily Constructs
Recombinant C3 exoenzyme from C. botulinum (Nemoto et al.,
1991) was a kind gift of Dr. Narito Morii, Kyoto University, Japan,
or was obtained commercially from Calbiochem–Novabiochem
Corp. (La Jolla, CA). It was solubilized at a concentration of 1 mg/ml
in 0.15 M NaCl/20 mM Hepes buffer, pH 7.5.
The Rho constructs used in this study were derived from a
human RhoA cDNA, and the Rac and Cdc42 constructs were
derived from both human and Drosophila cDNAs. These proteins
include wild-type versions [human WTRho and WTCdc42, Dro-
sophila WTDrac1 (Drac1 is also called DRacA) and WTCdc42],
constitutively active versions (human V14RhoA, V12Rac, and
V12Cdc42, Drosophila V12Drac1), and dominant negative versions
(human N19RhoA and N17Cdc42, Drosophila N17Drac1). The
dominant negative (threonine-to-asparagine mutation at amino
acid residue 19) and constitutively active (glycine-to-valine muta-
tion at amino acid residue 14) forms of Rho were generated using
two-round PCR mutagenesis (Zhao et al., 1995), with the human
Rho cDNA as template. Similar procedures were used for the
production of human V12Rac1, N17Cdc42, and V12Cdc42. Mu-
tagenesis to produce N17Drac1 and V12Drac1 was described pre-
viously (Harden et al., 1995). The wild-type and mutant forms of
the p21s were cloned into the pGEX-2TK vector, expressed as
glutathione S-transferase fusion proteins, and isolated by thrombin
cleavage of fusion proteins as described previously (Kozma et al.,
1995). Purified proteins were routinely analyzed for activity using
binding or activation of kinase targets (Manser et al., 1995; Leung
et al., 1995) or morphological effects as assays (Kozma et al., 1995,
1997; Leung et al., 1996).
Microinjections
Micropipets were pulled from capillary stock with a glass fila-
ment (1.2 mm outer diameter and 0.68 mm inner diameter, A-M
Systems, Inc., Everett, WA) using methods described previously
(Kiehart, 1981, 1982) except the pipet holder was bored to accept
the larger diameter capillary glass. Pipets were backfilled with 0.5
to 2 ml of injection solution and were manipulated with a Narash-
ige micromanipulator (Model M0-102, Narashige, Tokyo, Japan).
For embryos that were microinjected twice, the second micro-
injection occurred 30 to 45 min after pre-microinjection of the first
p21 protein. Injection of the second p21 was delivered into the
embryo using the same insertion site as the first injection to avoid
mechanical disruption of the embryo.
For all of the agents analyzed, 30 to 100 embryos were injected.
Results reflect effects observed in approximately 95–100% of
injected embryos. Variable effects at a low frequency were observed
with all agents injected, including buffers alone, and were presum-
ably the result of mechanical perturbation that was infrequently
introduced during the microinjection itself.
Microscopy, Image Acquisition, and Volume
Analysis
Embryos were injected and imaged on a Zeiss Axioplan micro-
scope (Carl Zeiss Inc., Thornwood, NY). Standard epifluorescence
images were acquired with a Hamamatsu C4880 camera
(Hamamatsu, Bridgewater, NJ) using MetaMorph software on a
IBM PC (Universal Imaging, West Chester, PA) and processed as
described elsewhere (Kiehart et al., 1994). Microinjections were
observed with either a 403, 0.9 NA, a 253, 0.8 NA multi-
immersion objective or a 103, 0.25 NA dry objective, 0.9 NA
condenser and the zoom optivar was set at 1.83.
The volume injected was determined based on modification of a
strategy devised by Lee (1989). All solutions were “doped” by
adding a small volume (1/20 v/v) of a fluorescent tracer, rhodamine-
labeled dextran (1 mg/ml final concentration, 60–90 kDa, Molecular
Probes, Eugene, OR). A low NA objective was used so that the
depth of field was sufficient to both excite and image the microin-
jected fluorochromes in the embryo. Embryos were imaged with a
103 objective using epifluorescent optics just before and just after
microinjection. The “before” background image was subtracted
from the “after microinjection” image and fluorescent intensity
was integrated using MetaMorph software (Universal Imaging).
Diffusion caused the microinjected material to spread, but four
images taken 20 s apart showed an average change in fluorescent
integrated intensity of only 1.5%. Thus, during early times after
microinjection, the integrated intensity remains essentially con-
stant and is an excellent indicator of the true microinjected
volume. The integrated intensity with background subtracted was
compared directly to a standard curve of volume vs fluorescence to
estimate the amount of material microinjected. The standard curve
was generated by plotting the intensity (again with background
subtracted) of a series of spheres of different radii made by micro-
injecting the doped aqueous injection solution into the halocarbon
oil adjacent to the embryos. The intensity of such spheres was
linear with volume (a cubed function of the radius) throughout the
range of microinjected volumes. The volume of material microin-
jected averaged 5% (approximately 3.5 3 10210 L) of total embryo
volume (approximately 7 3 1029 L) with a range of 2–15%.
Fixation and Fluorescence
For experiments in which microinjection was followed by
fixation and immunofluorescence analysis, approximately 30
embryos were mounted on a single coverslip. It took approxi-
mately 5–10 min to microinject all of the embryos on one slide,
and those that were not at the appropriate stage of development
were destroyed. All the embryos were removed from the cover-
slip simultaneously and fixed (thus, individual embryos were
not followed).
For filamentous actin staining, embryos were fixed in 37%
formaldehyde 1:1 with heptane for 2 min and rinsed in PBT (PBS;
138 mM NaCl, 2.7 mM KCl, 10.2 mM Na2HPO4, 1.8 mM
KH2PO4, pH 7.4, 0.1% Triton X-100). This high concentration of
formaldehyde was found to be necessary to maintain the integ-
rity of the microinjected embryos. After removing the vitelline
membrane with double-stick tape and a tungsten needle (Wie-
schaus and Nu¨sslein-Volhard, 1986), the embryos were blocked
for 30 min to 1 h in 25% goat serum, PBS, 0.3% Triton X-100.
Incubation with 1:500 (4 3 1024 units/ml) rhodamine phalloidin
(Molecular Probes) in incubation solution (5% goat serum, PBS,
0.3% Triton X-100) was performed overnight at 4°C. Embryos
were washed in PBT three times for 10 min each and mounted in
the DNA stain SPIF that we synthesized in the lab (Lundell and
Hirsh, 1994). For other fixations, embryos were fixed in 4%
formaldehyde as described by Young et al. (1991). Immunostain-
ing incubations were performed overnight at 4°C in incubation
solution using 1:125 anti-b-tubulin antibody (Amersham Corp.,
153Rho Inhibition and Cdc42 Activation Disrupt Cytokinesis in Drosophila
Copyright © 1998 by Academic Press. All rights of reproduction in any form reserved.
Arlington Heights, IL), 1:200 anti-lamin antibody (Smith et al.,
1987), and 1:500 anti-nonmuscle myosin antibody (Kiehart and
Feghali, 1986). Following washes, the embryos were stained for
1 h at room temperature with 1:4000 secondary antibody Cy3,
Cy5, or FITC (Jackson ImmunoResearch, West Grove, PA). Fixed
and stained embryos were mounted in SPIF and viewed with a
Zeiss LSM 410 confocal microscope using the same objectives as
described above (Carl Zeiss Inc.). For all experiments in which
microinjection was followed by fixation, the number of embryo
specimens imaged after fixation and staining ranged from 21 to
FIG. 1. DIC timelapse documents cellularization in an uninjected control embryo and disruption of cellularization in a C3 exoenzyme
microinjected embryo. Time-lapsed DIC images of an uninjected control embryo show the nuclei and the progression of the invaginating
cleavage furrows (A–C, arrow) during cellularization and a halt in the invagination of the cleavage furrows and progressive disorganization
of the nuclei in a C3 exoenzyme microinjected embryo (D–F). In the control embryo, the cleavage furrows can be seen in the beginning of
cellularization (A, arrow) and continue to invaginate between the nuclei that are equidistantly spaced at the cortex of the syncytium. In
this embryo, the invagination progresses more rapidly at the poles of the embryo (the posterior pole is shown here). The slow phase of
cellularization continues until about the time that the cellularization front is even with the basal half of the nuclei (A, arrow). The nuclei
elongate as the cleavage furrows progress inward at an increased rate during the fast phase of cellularization, which culminates in the
formation of approximately 6000 individual cells (C). In a C3 exoenzyme microinjected embryo, the cleavage furrows halt in their inward
progression (D), initially at the dorsal surface of the embryo (top of panel), which is nearer to the site of injection. In this region (D, arrow),
the cleavage furrows are no longer discernible and the nuclei are not in a regular array. The ventral surface (away from the site of
microinjection) is also affected within 28 min with a similar loss of cleavage furrows and movement of nuclei. As the nuclei leave the plane
of focus, they appear to move radially relative to each other (E, double arrows). By 54 min this embryo shows no evidence of cellularization
and halts in development. Scale bar is 25 mm. Times for each frame are given in minutes and seconds from the time of microinjection. A,
T 5 15:369; B, T 5 23:249; C, T 5 39:009; D. T 5 15:079; E, T 5 41:379; and F, T 5 54:529.
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85. Images were processed and overlaid using Adobe Photoshop
(Adobe Systems, Inc., Mountain View, CA) and Canvas software
(Deneba Systems, Inc., Miami, FL).
Chymotrypsin Cleavage of C3 Exoenzyme,
N19Rho, and V12Cdc42
a-Chymotrypsin attached to agarose beads (Sigma) was resus-
pended at 6 mg of beads per 100 ml dH2O. The beads were pelleted
and resuspended in 100 ml of 0.15 M NaCl/20 mM Hepes buffer, pH
7.5. Approximately 125 mg of C3 exoenzyme, N19Rho, or
V12Cdc42 was incubated with the beads for 1 h at room tempera-
ture with rotation followed by 20 min at 37°C. The beads were
pelleted by spinning for 5 min at 16,000g (Brinkman Instruments,
Westbury, NY) and a portion of the supernatant was run on a
SDS–PAGE to confirm that the proteins were degraded (data not
shown).
RESULTS
Microinjection of C3 Exoenzyme, Dominant
Negative Rho, or Constitutively Active Cdc42
Inhibits Cellularization and Blocks Subsequent
Development
The Rho inhibitor C3 exoenzyme and wild-type, consti-
tutively active (V12 or 14) or dominant negative (N17 or 19)
forms of Rho, Rac, and Cdc42 proteins were each microin-
jected into cellularization stage embryos. The embryos
were monitored by DIC time-lapse microscopy to analyze
the effect of these proteins on the process of cellularization
and embryogenesis.
Microinjection of C3 exoenzyme, human dominant
negative N19Rho, or human constitutively active
V12Cdc42 halts cellularization and embryogenesis in a
dose-dependent and local fashion. The resulting pheno-
types of these three microinjections are indistinguish-
able: progression of the cellularization front halts, the
cleavage furrows collapse, and further development is
arrested (Figs. 1D–1F). Progression of the cellularization
front near the site of microinjection (Fig. 1D, arrow) stops
within 3 to 7 min of injection. The equidistant spacing of
the nuclei that characterizes control embryos (Figs. 1A–
1C; reviewed in Foe et al., 1993; Sullivan and Theurkauf,
1995; Miller and Kiehart, 1995) is disrupted and the
nuclei appear to move relative to each other while
remaining at the cortex (Fig. 1E, double arrows). Subse-
quent to arrest of the inward progression of the cellular-
ization front, it does not appear as if the cleavage furrows
retract. Nevertheless, within 3 to 7 min the cleavage
furrows are no longer discernible and by 15 min after
injection the nuclei begin to fall away from the surface of
the embryo and are no longer found in a regular array at
the cortex (Fig. 1D, arrow). As time after microinjection
increases, the disruption of the cellularization front ex-
tends into the anterior regions of the embryo. In addition
to the disruption of cellularization, further progression
into gastrulation is blocked.
In contrast, control, uninjected embryos and embryos
microinjected with buffer, rhodamine–dextran, or chymo-
tryptically cleaved C3 exoenzyme, N19Rho, or V12Cdc42
did not exhibit disruption of cellularization. In addition,
embryos microinjected with wild-type versions of Rho, Rac,
TABLE 1
Dose Dependence of Rho Inhibition
Concentration of
injected agents
Number of
injected
embryos (n) No effect
Mild
perturbation
Strong
perturbation
Complete
disruption
C3 exoenzyme
Full strength (1 mg/ml) 85 2 (2.4%) 4 (4.7%) 33 (38.8%) 46 (54.1%)
1:3 (0.33 mg/ml) 21 7 (33.3%) 3 (14.3%) 6 (28.6%) 5 (23.8%)
1:10 (0.1 mg/ml) 23 17 (73.9%) 2 (8.7%) 4 (17.4%) 0
N19RhoA
Full strength (1 mg/ml) 30 3 (10%) 0 21 (70.0%) 6 (20.0%)
1:2 (0.5 mg/ml) 13 6 (46.2%) 2 (15.4%) 4 (30.8%) 1 (7.7%)
1:40 (0.025 mg/ml) 11 9 (81.8%) 2 (18.2%) 0 0
V12Cdc42
Full strength (1 mg/ml) 71 4 (5.6%) 8 (11.3%) 47 (66.2%) 12 (16.9%)
Note. The data tabulated include the number of embryos (n) injected with each substance and the number of embryos (and percentage
of the total injected) that responded in a particular manner. The four categories include no effect, normal hexagonal array and nuclear
positioning; mild perturbation, aggregate formation and disruption of a normal hexagonal array and partial disorganization of nuclear
positioning; strong perturbation, extreme disorganization of hexagonal array/partial array loss and disorganization and aggregation of
nuclei; and complete disruption, complete loss of organized actin structures and disorganization and aggregation of nuclei.
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or Cdc42 and those microinjected with V14Rho, N17Rac,
V12Rac, or N17Cdc42 proceeded through cellularization
and into gastrulation normally.
Both the Inhibition of Rho Activity and the
Activation of Cdc42 Disrupt the Actomyosin-Based
Hexagonal Array and Nuclear Organization
To investigate the mechanism by which C3 exoenzyme,
N19Rho, or V12Cdc42 disrupted cellularization, we fixed
microinjected embryos and stained them with reagents to
detect the actin-based hexagonal array and nuclei (Figs. 2
and 3; Table 1). Control embryos have normal, evenly
spaced actomyosin hexagonal arrays (red, Figs. 2A and 2B)
with individual nuclei (green in the overlay panel of Fig. 2A)
in each newly forming cell of the cellularizing syncytial
blastoderm.
In contrast, microinjection of either C3 exoenzyme (Figs.
2E and 2F), N19Rho (Figs. 2C and 2D), or V12Cdc42 (Figs.
2G and 2H) generates the same phenotype: local disruption
of the actomyosin hexagonal array at the site of injection
and irregular spacing of the nuclei in regions corresponding
to actomyosin disruption (Fig. 2C, arrows). Only 2.4, 10.0,
and 5.6% of the embryos microinjected with C3 exoen-
zyme, N19Rho, and V12Cdc42, respectively, display a nor-
mal actomyosin hexagonal array and continue through
development. In the remaining microinjected embryos,
disruption occurs in a progressive, stepwise manner that is
dose dependent (Figs. 2 and 3; Table 1). The extent of
disruption is shown most clearly when nuclei are not
imaged (compare Fig. 2D with the overlay in Fig. 2C and the
control embryo in Fig. 2B). Another microinjected embryo
shows an example of a more global, severe disruption of the
hexagonal array and concomitant disorganization of the
nuclei (Figs. 2E and 2F). Antimyosin staining indicates that
the myosin, which colocalizes with the actin in the hex-
agonal array, is also disrupted in a comparable fashion (data
not shown). Similar to the results described above on live
embryos, fixed embryos demonstrated that the microinjec-
tion of chymotryptically cleaved C3 exoenzyme, N19RhoA,
or V12Cdc42 had no effect on the hexagonal array or
spacing of the nuclei. Likewise, embryos injected with
buffer alone or embryos injected with any p21 construct
other than N19RhoA or V12Cdc42 appeared normal.
The extent of phenotyes that result from the microinjection
of C3 exoenzyme (Fig. 3), N19Rho, and V12Cdc42 is dose
dependent (Table 1). Microinjection of increasing amounts (tip
concentrations from 0.025 to 1 mg/ml of protein; volumes
averaging approximately 3.5 3 10210 L, equivalent to ;5% of
the embryo volume, ranging from 1.0 3 1029 to 9.9 3 10211 L)
yielded progressively more disrupted phenotypes. The most
subtle phenotype seen is the apparent breakdown of the
hexagonal array into particulate aggregates of phalloidin- and
myosin-staining material (Fig. 3B, arrows). The formation of
these particulate aggregates of actin and myosin generally
precedes the absolute loss of the hexagonal array pattern near
the site of microinjection (Fig. 3D). In more severely affected
embryos, the regular pattern of the hexagonal array is increas-
ingly disorganized and distorted around the injection site (Fig.
3C) encompassing approximately one-third of the embryo
length. Embryos microinjected with the largest volumes of
the highest concentration of protein displayed the greatest
degree of disruption of the hexagonal array, often affecting the
entire embryo (Figs. 3E and 3F). No remnants of the previously
organized actin structures remain in these embryos.
By varying the period of time between the microinjection of
C3 exoenzyme, N19Rho, or V12Cdc42 and fixation, we ob-
tained a rough estimate of the kinetics of function of these
agents. Such observations confirm our data on living material.
At the earliest time points (5–10 min after microinjection),
fixed embryos showed initial disruptive effects on the hexago-
nal array. In general, in the en face views that we use to
examine the hexagonal array, the nuclei appeared to have a
normal distribution and remained close to the surface of the
embryo. As the time between microinjection and fixation was
incrementally increased up to 1 h, disruption of the hexagonal
array increased, and the nuclei became progressively more
disorganized and fell away from the surface of the embryo. In
some of the most severely affected embryos, the nuclei not
only aggregated, but chromatin also became hypercondensed
(Figs. 4A and 4B, arrow; compare with Fig. 2A). Antilamin
staining shows that the nuclear membrane is intact in C3
exoenzyme, N19Rho, and V12Cdc42 microinjected embryos
in areas of array disruption (Figs. 4C and 4D), even though the
nuclei are disorganized and aggregated.
Inhibition of Rho Activity and Activation of Cdc42
Function Alter the Actin Cytoskeleton in
Pre-cellularization Staged Embryos.
In addition to the disruption of cellularization that resulted
from microinjection of C3 exoenzyme, N19Rho, or
V12Cdc42, we observed similar disruptive effects on meta-
phase furrows during precellularization stages (reviewed in
FIG. 2. C3 exoenzyme, N19Rho, and V12Cdc42 disrupt the actin hexagonal array and the distribution of nuclei in microinjected embryos.
Confocal imaging of the actin-based hexagonal array and nuclei in fixed embryos. Rhodamine phalloidin staining alone (red) is shown in
B, D, F, and H, and overlay images with the DNA specific stain SPIF (green) and phalloidin are shown in A, C, E, and G. A and B show the
normal hexagonal array of an uninjected embryo. One nucleus is present in each newly forming cell as the hexagonal array invaginates
between individual nuclei to form individual cells. After the microinjection of N19Rho into a cellularization stage embryo, the hexagonal
array becomes disrupted and in these regions of disruption, the nuclei are aggregated (C, arrows; D). Another embryo showing a more severe
phenotype after the microinjection of C3 exoenzyme displays little visible remnant of the hexagonal array and severely disorganized nuclei
(E, F). A V12Cdc42 microinjected embryo (G, H) phenocopies the N19Rho and C3 exoenzyme disrupted embryos. Scale bars are 25 mm.
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Foe et al., 1993; Miller and Kiehart, 1996). Metaphase furrows
are invaginations of the plasma membrane that form during
metaphase of mitotic cycles 10–13 to create mitotic domains
and prevent adjacent mitotic figures from interacting with one
another or “colliding.” Pre-cellularization embryos at mitotic
stages 10–13 were microinjected with C3 exoenzyme,
N19Rho, or V12Cdc42, monitored by DIC timelapse, aged
appropriately, and then fixed and stained with rhodamine
phalloidin or antibodies to actin and myosin. Both fixed and
live specimens demonstrate a halt in development during
precellularization stages: the microinjected embryos did not
form the metaphase furrows that separate adjacent spindles
during mitosis in the cellular blastoderm and did not proceed
into cellularization stages. Fixed embryos also exhibited a
disruption in the regular staining pattern of actomyosin and
nuclear mislocalization similar to the disruption seen during
cellularization.
C3 Exoenzyme, N19Rho, and V12Cdc42 Do Not
Affect the Microtubule Architecture
To ascertain whether C3 exoenzyme, N19Rho, and
V12Cdc42 were influencing the microtubule cytoskeleton,
microinjected and control embryos were fixed and stained
to visualize tubulin distribution. Anti-b-tubulin staining
reveals intact microtubule baskets that envelop each
nucleus at cellularization (Figs. 4E and 4F) and produce a
zone of yolk-free cytoplasm that extends from the embryo
surface to just below the basal surface of the nuclei. These
microtubule baskets show normal integrity in microin-
jected embryos, although they are slightly distorted in their
orientation, consistent with the abnormal positioning of
nuclei in C3 exoenzyme, N19Rho, and V12Cdc42 injected
embryos. Additionally, the microtubule-based saltatory
vesicle movement is not disrupted when viewed by DIC
time-lapse microscopy (data not shown; see Foe and Al-
berts, 1983).
Pre-microinjection of V14Rho or WTRho
Ameliorates the Effects of C3 Exoenzyme and
N19Rho; pre-microinjection of V14Rho or
WTCdc42 Ameliorates the Effects of V12Cdc42
Microinjection of constitutively active Rho (V14Rho),
wild-type Rho (WTRho), or wild-type Cdc42 (WTCdc42)
protein into cellularization stage embryos had no effect on
the hexagonal array, distribution of nuclei, or progress of
development. These embryos completed cellularization
with an intact hexagonal array and proceeded into gastru-
lation in a manner comparable to uninjected control em-
bryos. However, as described above, only 2.4% of C3
exoenzyme microinjected embryos, 10.0% of N19Rho mi-
croinjected embryos, and 5.6% of V12Cdc42 microinjected
embryos were scored as normal (an intact hexagonal array
and normal spacing of nuclei). To investigate further the
mechanism by which cellularization is disrupted by C3
exoenzyme, N19Rho, or V12Cdc42 microinjection, we pre-
microinjected target embryos with V14Rho, WTRho, or
WTCdc42. When V14Rho was microinjected prior to the
microinjection of either C3 exoenzyme or N19Rho, the
percentage of normal phenotypes rose to 20.8 and 20.0%,
respectively. An even greater increase in the percentage of
normal phenotypes was seen for embryos microinjected
with WTRho prior to microinjection of C3 exoenzyme
(58.0%) or N19Rho (69.2%). Likewise, microinjection of
V14Rho or WTCdc42 prior to microinjection of V12Cdc42
increased the percentage of normal phenotypes from 5.6 to
85.7 and 89.7%, respectively. Thus, the disruptive effects of
N19Rho and V12Cdc42 could be ameliorated by pre-
microinjection of WTRho and V14Rho or WTCdc42 and
V14Rho, respectively.
DISCUSSION
Here we analyze the role of the Rho subfamily of signal-
ing molecules in the actomyosin-driven process of Dro-
sophila cellularization, a specialized form of cytokinesis.
Using a pharmacological approach that circumvents mater-
nally loaded gene products, we find that inhibition of Rho
function or activation of Cdc42 disrupts the actomyosin
cytoskeleton and blocks the invagination of the cellulariza-
tion front in D. melanogaster embryos. The membrane
furrows are abolished, nuclear position at the cortex is
disrupted, and development halts. This disruption of cellu-
larization was specific because the microinjection of buffer
alone or of wild-type Rho, Rac, or Cdc42, dominant nega-
tive Rac or Cdc42, and constitutively active Rho or Rac all
had no effect on cellularization. Moreover, C3 exoenzyme,
dominant negative N19Rho, and constitutively active
V12Cdc42 had no effect if they were predigested with
a-chymotrypsin. Embryos microinjected with any 1 of
these 13 control preparations completed cellularization and
proceeded into gastrulation without visible actomyosin
disruption, comparable to uninjected or buffer-injected em-
bryos.
FIG. 3. Rho inhibits actomyosin cytoskeletal function in a dose-dependent fashion. Confocal imaging shows the actin localization by
rhodamine phalloidin staining. A displays the normal hexagonal array of an uninjected embryo. B–F represent the progressively more severe
phenotypes of embryos that were injected with increasing concentrations of C3 exoenzyme (0.1 to 1 mg/ml). B displays a mild phenotype
that shows aggregates (arrows) of phalloidin staining. C–E show the progressive disorganization of the hexagonal array and the partial loss
of organized actin patterns in some regions. F represents the most severely disrupted phenotype with total loss of the organized hexagonal
array after injection with the highest dose of C3 exoenzyme. Scale bars are 25 mm.
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N19Rho and V12Cdc42 Principally Disrupt the
Actomyosin Cytoskeleton
This pharmacological approach of analyzing Rho subfam-
ily protein function in cellularization allowed us to study
the roles of these small p21 GTPases with spatial and
temporal resolution. In this manner, we found that the
disruption of cellularization by C3 exoenzyme, N19Rho, or
V12Cdc42 is dose-dependent and affects the site of micro-
injection most strongly. In embryos microinjected with C3
exoenzyme, N19Rho, or V12Cdc42, precellularization
metaphase furrows were not established and cellularization
stage cleavage furrows were not retracted; instead, they
halted their inward progression and then collapsed in place,
causing the invaginations to disappear. These observations
suggest that inhibition of Rho activity and constitutive
activation of Cdc42 function result in the immediate inhi-
bition of the function of the actomyosin cytoskeleton in
two distinct cytokinetic events. Since disorganization of
the equidistant spacing of the cortical nuclei during cellu-
larization occurred only after the cleavage furrows had
begun collapsing, we interpret the disturbance of the
nuclear array as a secondary consequence of inhibition of
actomyosin function. It is likely that this nuclear disorga-
nization is due to a disruption in the interaction between
the microtubule basket that sits over each nucleus and the
cortical actin which maintains the nuclei at the cortex.
Consistent with this interpretation is the observation that
intact microtubule baskets are associated with each
nucleus, but are improperly oriented (Figs. 4C and 4D).
Finally, in the most severely disrupted embryos, some of
the nuclei display hypercondensed chromatin that may be
due to the onset of apoptosis (Figs. 4A and 4B). The late
timing with which these affects appear suggests that they
are also secondary.
Rho–Cdc42 Antagonism
Based on the data presented here, we suggest that the
actomyosin hexagonal array of the cellularizing Drosophila
embryo is in many ways analogous to the Rho-induced
stress fibers observed in cultured mammalian cells: both are
Rho-dependent structures (Ridley and Hall, 1992), neither
structure requires Rac or Cdc42 function (Nobes and Hall,
1995; Kozma et al., 1995), both structures contain F-actin
and myosin with contractile activity (Young et al., 1991;
Thomas and Kiehart, 1994; Edwards et al., 1996;
Chrzanowska-Wodnicka and Burridge, 1996; Machesky and
Hall, 1997), and both structures can be disassembled by
Cdc42 activity (Kozma et al., 1995; Sells et al., 1997). Given
these similarities between the actomyosin hexagonal array
and Rho-induced stress fibers in cultured mammalian cells, it
is possible that the mechanisms of regulation are similar
between the two systems. Nevertheless, in cultured mamma-
lian cells, Rho and Cdc42 effectors function antagonistically
in that two distinct small GTPase protein-driven processes,
the formation of stress fibers driven by Rho and the formation
of filopodia driven by Cdc42, compete (Kozma et al., 1995,
1997). Disruption of function of either of these two GTPase
proteins causes distinct phenotypes. In Drosophila cellulariza-
tion, disruption of either Rho or Cdc42 causes the same
phenotype: cellularization ceases and the actomyosin cy-
toskeleton is disrupted. One possibility is that Rho and Cdc42
effectors function antagonistically, but in contrast to the
mammalian case the two phenotypes are indistinguishable.
By this hypothesis, Rho and Cdc42 function in independent
pathways: Rho effector function is required for cellularization
and maintenance of the actomyosin hexagonal array, whereas
Cdc42 effector function antagonizes this process. Cdc42 effec-
tors might inhibit Rho effector function directly, thereby
phenocopying the disruption of Rho function generated by the
microinjection of C3 exoenzyme or N19Rho.
An alternate hypothesis that explains these data requires
a mechanism of Rho subfamily regulation of the actomyo-
sin cytoskeleton in a single pathway that depends only on
Rho effector function during Drosophila cellularization. By
this hypothesis, Rho and Cdc42 share a common factor that
is required for Rho function, but is sequestered by GTP-
bound Cdc42. Thus, microinjection of C3 exoenzyme or
dominant negative N19Rho inactivates or competes with
endogenous Rho protein, respectively, resulting in the sub-
sequent lack of activation of downstream Rho effectors.
Likewise, microinjection of constitutively active, GTP-
bound V12Cdc42 would sequester the hypothesized endog-
enous shared component, thereby preventing the activation
of Rho effectors that may be required for the maintenance
and/or regulation of the actomyosin cytoskeleton. The
amelioration of C3 exoenzyme, N19Rho, or V12Cdc42
induced disruption by pre-microinjection of wild-type and
constitutively active Rho or wild-type Cdc42 supports the
existence of a shared component required for Rho function
FIG. 4. Rho inhibition and Cdc42 activation sometimes result in the hypercondensation of chromatin, but do not affect the nuclear
membrane or the microtubules. (A and B) Confocal imaging of a N19Rho microinjected embryo shows a rare hypercondensation of
chromatin as detected by SPIF staining (A, green) in regions where the hexagonal array is disrupted as detected by phalloidin staining (B,
red). (C and D) Confocal imaging shows that even in regions of actin disruption, the nuclei maintain intact nuclear membranes. Nuclei
stained with anti-lamin antibodies (C, green) are aggregated in this C3 exoenzyme injected embryo in regions where the actin-based
hexagonal array, stained by rhodamine phalloidin (D, red), is disrupted. (E and F) The microtubule baskets that sit over each nucleus at the
cortex of the syncytial blastoderm are intact in this C3 exoenzyme microinjected embryo (antitubulin staining: E, green, arrow) even in
regions where the hexagonal array is completely disrupted (rhodamine phalloidin: F, red). The microtubules appear intact, although perhaps
somewhat distorted in their orientation compared to uninjected embryos of this stage (data not shown). Scale bars are 25 mm.
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because such pre-microinjections would be expected to
provide additional Rho-bound shared factor or to activate
Rho effector function directly.
Maintenance/Regulation of the Actomyosin
Cytoskeleton during Cellularization by Rho
Subfamily Effectors
Known proteins that are potentially involved in the
maintenance and/or regulation of the actomyosin cytoskel-
eton include the Rho subfamily effectors Rho-binding ki-
nase (ROK), myotonic dystrophy kinase-related Cdc42-
binding kinase (MRCK), and p21-activated protein kinase
(PAK). Recently, a Drosophila homologue of MRCK has
been isolated (Luo et al., 1997). ROK, MRCK, and PAK are
serine/threonine kinases that are known to phosphorylate
myosin regulatory light chain predominantly at serine-19
(Tuazon et al., 1982; Tuazon and Traugh, 1984; Amano et
al., 1996; Leung et al., 1996, 1998). Phosphorylation at this
amino acid is known to result in the activation of myosin
function (Tan et al., 1992; Kamisoyama et al., 1994) and the
contraction of the actomyosin cytoskeleton which results
in the formation of stress fibers and focal adhesion com-
plexes in cultured cells (Chrzanowska-Wodnicka and Burr-
idge, 1996). ROK also phosphorylates a subunit of the
myosin light chain phosphatase and inhibits its function
(Kimura et al., 1996; Matsui et al., 1996), thereby increasing
the amount of phosphorylated, active myosin.
Although the Rac and Cdc42 effector PAK (Manser et al.,
1994) has been implicated in the disruption of actin stress
fibers (Lim et al., 1996; Sells et al., 1997; Manser et al.,
1997), microinjection of constitutively active V12Rac (and
either WTCdc42 or WTRac) did not phenocopy the disrup-
tion of the actomyosin cytoskeleton observed in C3 exoen-
zyme, dominant negative N19Rho, or constitutively active
V12Cdc42 microinjected embryos. We eliminated the pos-
sibility that our Cdc42 and Rac proteins were not biologi-
cally active and hence not producing a disruptive phenotype
by activity assays that indicated functional p21 GTPase
proteins (data not shown). Additionally, the direct microin-
jection of active a/b PAK during cellularization produced
normal, control phenotypes (unpublished observations),
suggesting that PAK function is not the source of V12Cdc42
induced disruption. Although Rac and Cdc42 are clearly
involved in other actomyosin-driven morphological pro-
cesses in Drosophila development (Luo et al., 1994; Harden
et al., 1995; Riesgo-Escovar et al., 1996; Strutt et al., 1997;
Harden et al., in preparation), a requirement for the func-
tion of only one Rho subfamily member is not unusual and
has been established in other stages of Drosophila develop-
ment (Murphy and Montell, 1996; Kaufmann et al., 1998).
Rho subfamily function may mediate alterations in the
actomyosin cytoskeleton through the regulation of actin
directly, of myosin directly, or of actin in conjunction with
myosin. Here we speculate on the role myosin may play in
this process. Since myosin function is necessary for cytoki-
nesis and cellularization (Mabuchi and Okuno, 1977; Kie-
hart et al., 1982, 1990; De Lozanne and Spudich, 1987;
Karess et al., 1991), a mechanism whereby myosin is
regulated through phosphorylation by a Rho effector func-
tion is attractive. Because it is likely that force production
for cytokinesis continuously requires activated myosin, it
would be predicted that inhibition of Rho activity would
block further progression of the cytokinetic furrow canals.
Thus, agents that interfere with Rho activity, such as C3
exoenzyme and N19Rho, would be expected to prevent the
activation of myosin function and the formation of myosin
bipolar filaments. It is possible that Rho effects on myosin
can also explain the observed changes in the organization of
actin. Indeed, Rho activity in the bundling of preexisting
actin filaments (Machesky and Hall, 1997) may be directly
or indirectly dependent on myosin function. Bipolar myosin
filament formation can stimulate the formation and orga-
nization of filamentous actin (reviewed in Tan et al., 1992);
therefore, inhibition of myosin function may also explain
the observed disruption of actin distribution. A similar
correlation is observed in renal glomerular mesangial cells,
where C3 exoenzyme inactivates Rho function and con-
comitantly leads to the disruption of actin stress fibers and
dephosphorylation of myosin regulatory light chain (Kreis-
berg et al., 1997).
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